These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27679514)

  • 21. Effect of treatment for 6 months with human parathyroid hormone (1-34) peptide in ovariectomized cynomolgus monkeys (Macaca fascicularis).
    Jerome CP; Johnson CS; Vafai HT; Kaplan KC; Bailey J; Capwell B; Fraser F; Hansen L; Ramsay H; Shadoan M; Lees CJ; Thomsen JS; Mosekilde L
    Bone; 1999 Sep; 25(3):301-9. PubMed ID: 10495134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Glucocorticoid-induced osteoporosis and rheumatic diseases. Pathogenesis, prevention and treatment].
    Di Munno O; Delle Sedie A
    Reumatismo; 2006; 58(1):11-21. PubMed ID: 16639483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Secondary osteoporosis or secondary contributors to bone loss in fracture. Therapeutic strategy for glucocorticoid-induced osteoporosis].
    Hayakawa N; Suzuki A
    Clin Calcium; 2013 Sep; 23(9):1337-44. PubMed ID: 23999371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of glucocorticoid induced osteoporosis with alendronate or alfacalcidol: relations of change in bone mineral density, bone markers, and calcium homeostasis.
    Jacobs JW; de Nijs RN; Lems WF; Geusens PP; Laan RF; Huisman AM; Algra A; Buskens E; Hofbauer LC; Oostveen AC; Bruyn GA; Dijkmans BA; Bijlsma JW
    J Rheumatol; 2007 May; 34(5):1051-7. PubMed ID: 17407214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An MSC bone-homing compound, Rab001, increases bone mass and reduces the incidence of osteonecrosis in a glucocorticoid-induced osteonecrosis mouse model.
    Jiang M; Liu L; Xiang X; Liang R; Qin X; Zhao J; Wei Q
    Clin Exp Pharmacol Physiol; 2021 May; 48(5):770-781. PubMed ID: 33319413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
    Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA
    Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preventive effects of berberine on glucocorticoid-induced osteoporosis in rats.
    Xu D; Yang W; Zhou C; Liu Y; Xu B
    Planta Med; 2010 Nov; 76(16):1809-13. PubMed ID: 20577944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.
    Boutsen Y; Jamart J; Esselinckx W; Devogelaer JP
    J Bone Miner Res; 2001 Jan; 16(1):104-12. PubMed ID: 11149473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Denosumab in the treatment of glucocorticoid-induced osteoporosis.
    Coskun Benlidayi I
    Rheumatol Int; 2018 Nov; 38(11):1975-1984. PubMed ID: 30019224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapy of male osteoporosis with parathyroid hormone.
    Bilezikian JP; Kurland ES
    Calcif Tissue Int; 2001 Oct; 69(4):248-51. PubMed ID: 11730261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of human parathyroid hormone (1-34), LY333334, on bone mass, remodeling, and mechanical properties of cortical bone during the first remodeling cycle in rabbits.
    Mashiba T; Burr DB; Turner CH; Sato M; Cain RL; Hock JM
    Bone; 2001 May; 28(5):538-47. PubMed ID: 11344054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucocorticosteroid-induced osteoporosis in adult primiparous Göttingen miniature pigs: effects on bone mineral and mineral metabolism.
    Scholz-Ahrens KE; Delling G; Stampa B; Helfenstein A; Hahne HJ; Açil Y; Timm W; Barkmann R; Hassenpflug J; Schrezenmeir J; Glüer CC
    Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E385-95. PubMed ID: 17456640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth hormone increases cortical and cancellous bone mass in young growing rats with glucocorticoid-induced osteopenia.
    Ortoft G; Andreassen TT; Oxlund H
    J Bone Miner Res; 1999 May; 14(5):710-21. PubMed ID: 10320519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucocorticoid-induced osteoporosis: an update on current pharmacotherapy and future directions.
    Bultink IE; Baden M; Lems WF
    Expert Opin Pharmacother; 2013 Feb; 14(2):185-97. PubMed ID: 23317448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allogeneic Mesenchymal Stem Cell Therapy Promotes Osteoblastogenesis and Prevents Glucocorticoid-Induced Osteoporosis.
    Sui B; Hu C; Zhang X; Zhao P; He T; Zhou C; Qiu X; Chen N; Zhao X; Jin Y
    Stem Cells Transl Med; 2016 Sep; 5(9):1238-46. PubMed ID: 27365487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does early PTH treatment compromise bone strength? The balance between remodeling, porosity, bone mineral, and bone size.
    Burr DB
    Curr Osteoporos Rep; 2005 Mar; 3(1):19-24. PubMed ID: 16036097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Glucocorticoid and Bone. Pathogenesis of glucocorticoid-induced osteoporosis].
    Tanaka Y
    Clin Calcium; 2014 Sep; 24(9):1289-94. PubMed ID: 25177000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Glucocorticoid-induced abnormality in bone remodeling.].
    Tanaka Y
    Clin Calcium; 2017; 27(12):1731-1738. PubMed ID: 29179167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Denosumab is effective toward glucocorticoid-induced osteoporosis patients complicated with rheumatic diseases regardless of prior anti-osteoporotic drugs.
    Iwamoto N; Okamoto M; Tsuji S; Endo Y; Takatani A; Shimizu T; Umeda M; Fukui S; Sumiyoshi R; Igawa T; Koga T; Kawashiri SY; Aramaki T; Ichinose K; Tamai M; Nakamura H; Origuchi T; Eguchi K; Ueki Y; Kawakami A
    J Bone Miner Metab; 2019 May; 37(3):554-562. PubMed ID: 30187273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucocorticoid-induced osteoporosis.
    Manelli F; Giustina A
    Trends Endocrinol Metab; 2000 Apr; 11(3):79-85. PubMed ID: 10707047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.